What does ESEAL-MEDICAL do?

ESEAL-MEDICAL is a healthcare practice in Waterloo. Private Limited, started on 19 July 2021, 2 establishments.

What is the address of ESEAL-MEDICAL?

The registered office of ESEAL-MEDICAL is located at Rue Noël 3A, 1410 Waterloo.

Is ESEAL-MEDICAL still active?

Yes. According to the CBE (30 October 2026) ESEAL-MEDICAL is active, legal situation “Normale toestand”, started on 19 July 2021.

Is ESEAL-MEDICAL registered on Peppol?

Yes, ESEAL-MEDICAL is registered on the Peppol network with ID 0208:0771560764.

What is the enterprise number of ESEAL-MEDICAL?

The enterprise number of ESEAL-MEDICAL is BE0771560764.

When was ESEAL-MEDICAL founded?

ESEAL-MEDICAL was founded on 19 July 2021.

Who are the directors of ESEAL-MEDICAL?

According to the 2025 annual accounts, the directors of ESEAL-MEDICAL are: Alfia LOVERDE, Ester Lucia SPINA.

Is ESEAL-MEDICAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 July 2021; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account; 2 establishments in the CBE.

How much profit did ESEAL-MEDICAL make in 2025?

ESEAL-MEDICAL posted a profit after taxes of € 12,488 in financial year 2025.

What is the revenue of ESEAL-MEDICAL?

As a small company, ESEAL-MEDICAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 79,867.

ESEAL-MEDICAL (Private Limited) - Waterloo - BE0771560764

Dossier ESEAL-MEDICAL, printed on 30 October 2026 from databakkes.be/en/0771560764/eseal-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 10 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

ESEAL-MEDICAL from Waterloo, company number BE0771560764, closed financial year 2025 with a result of € 12,488 after tax. For that financial year ESEAL-MEDICAL recorded a gross margin of € 79,867 and equity of € 89,110. Compared with financial year 2024, the result moved from € 24,635 to € 12,488. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.

What it is worth Growing

€ 89,110

▲ 16% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 12,488

▼ 49% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 3,958

▲ 196% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 87,110.

People and assets in 2025

Wage cost

€ 34,340

▲ 133% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 19,719

▼ 35% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 229,405

▼ 6% vs 2024

€ 35,186 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 8,582

▼ 21% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 31,502

▲ 53% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 65,615 Gross margin 2022: € 65,615 First fiscal year in the series	€ 46,130 Gross margin 2023: € 46,130 ▼ 30% vs 2022 (€ 65,615) Unfavourable step	€ 76,931 Gross margin 2024: € 76,931 ▲ 67% vs 2023 (€ 46,130) Favourable step	€ 79,867 Gross margin 2025: € 79,867 ▲ 4% vs 2024 (€ 76,931) Favourable step	▲ 4%
Profit after taxes	€ 32,447 Profit after taxes 2022: € 32,447 First fiscal year in the series	€ 17,541 Profit after taxes 2023: € 17,541 ▼ 46% vs 2022 (€ 32,447) Unfavourable step	€ 24,635 Profit after taxes 2024: € 24,635 ▲ 40% vs 2023 (€ 17,541) Favourable step	€ 12,488 Profit after taxes 2025: € 12,488 ▼ 49% vs 2024 (€ 24,635) Unfavourable step	▼ 49%
Equity	€ 34,447 Equity 2022: € 34,447 First fiscal year in the series	€ 51,988 Equity 2023: € 51,988 ▲ 51% vs 2022 (€ 34,447) Favourable step	€ 76,623 Equity 2024: € 76,623 ▲ 47% vs 2023 (€ 51,988) Favourable step	€ 89,110 Equity 2025: € 89,110 ▲ 16% vs 2024 (€ 76,623) Favourable step	▲ 16%
Total debts	€ 322,886 Total debts 2022: € 322,886 First fiscal year in the series	€ 292,528 Total debts 2023: € 292,528 ▼ 9% vs 2022 (€ 322,886) Favourable step	€ 277,361 Total debts 2024: € 277,361 ▼ 5% vs 2023 (€ 292,528) Favourable step	€ 269,489 Total debts 2025: € 269,489 ▼ 3% vs 2024 (€ 277,361) Favourable step	▼ 3%
Cash	-	€ 1,576 Cash 2023: € 1,576 First fiscal year in the series	€ 1,336 Cash 2024: € 1,336 ▼ 15% vs 2023 (€ 1,576) Unfavourable step	€ 3,958 Cash 2025: € 3,958 ▲ 196% vs 2024 (€ 1,336) Favourable step	▲ 196%
Retained profit	€ 32,447 Retained profit 2022: € 32,447 First fiscal year in the series	€ 49,988 Retained profit 2023: € 49,988 ▲ 54% vs 2022 (€ 32,447) Favourable step	€ 74,623 Retained profit 2024: € 74,623 ▲ 49% vs 2023 (€ 49,988) Favourable step	€ 87,110 Retained profit 2025: € 87,110 ▲ 17% vs 2024 (€ 74,623) Favourable step	▲ 17%
Bank debt	€ 208,810 Bank debt 2022: € 208,810 First fiscal year in the series	€ 269,976 Bank debt 2023: € 269,976 ▲ 29% vs 2022 (€ 208,810) Unfavourable step	€ 244,579 Bank debt 2024: € 244,579 ▼ 9% vs 2023 (€ 269,976) Favourable step	€ 229,405 Bank debt 2025: € 229,405 ▼ 6% vs 2024 (€ 244,579) Favourable step	▼ 6%
Balance sheet total	€ 357,333 Balance sheet total 2022: € 357,333 First fiscal year in the series	€ 344,516 Balance sheet total 2023: € 344,516 ▼ 4% vs 2022 (€ 357,333) Unchanged	€ 353,984 Balance sheet total 2024: € 353,984 ▲ 3% vs 2023 (€ 344,516) Unchanged	€ 358,600 Balance sheet total 2025: € 358,600 ▲ 1% vs 2024 (€ 353,984) Unchanged	▲ 1%

Key figures of ESEAL-MEDICAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to ESEAL-MEDICAL?

What happened at ESEAL-MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 30, 2026 New annual accounts for financial year 2025: profit of € 12,488 (▼ 49% vs 2024). filed late Source: NBB ↗
Aug 16, 2022 New establishment in Wavre. KBO
Jul 19, 2021 New establishment in Waterloo. KBO
Jul 19, 2021 Start of the company according to the CBE. KBO

In short

From € 32,447 profit in 2022 to € 12,488 profit in 2025.

Paid € 35,755 in corporate taxes since 2022.

Best year ever: 2022, with € 32,447 profit.

Original PDFs at the National Bank ↗

Management

Alfia LOVERDE Ester Lucia SPINA

ART-ES

ESEAL-MEDICAL

Behind ESEAL-MEDICAL are Alfia LOVERDE and Ester Lucia SPINA. Alfia LOVERDE is also behind ART-ES.

Directors

According to the 2025 annual accounts

Alfia LOVERDE

Director

Also active at: ART-ES

Ester Lucia SPINA

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Noël 3A

1410 Waterloo

2.320.083.612

Rue Noël 3 A

1410 Waterloo

Active since 19 July 2021

2.365.307.386

Chaussée de Louvain 43 box 1

1300 Wavre

Active since 16 August 2022

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0771.560.764

VAT number

BE 0771.560.764

Registered office

Rue Noël 3A, 1410 Waterloo

Names & denominations

ESEAL-MEDICAL

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

19 July 2021

Peppol

Active · Active since 9 Jan 2026

Contact

[email protected] +32471660945

Activities · NACE

Activiteiten van verpleegkundigen en verloskundigen

Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen

Verpleegkundige activiteiten

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

ESEAL-MEDICAL

Warning lights

Financials

What happened to ESEAL-MEDICAL?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions